Andrew von Eschenbach
Board Member
TriSalus Life Sciences, Inc. (TLSI)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Andrew von Eschenbach
Andrew von Eschenbach is recorded as Board Member at TriSalus Life Sciences, Inc. (TLSI). TriSalus Life Sciences, Inc. reported in an 8-K filed August 16, 2023 that Andrew von Eschenbach was appointed director, effective August 10, 2023.
“Upon the Closing, each of Mary Szela, Sean Murphy, Mats Wahlström, Andrew von Eschenbach, George Kelly Martin, David J. Matlin, Arjun Desai, Kerry Hicks and Anil Singhal were elected to serve as directors on the New TriSalus Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-08-10–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at TriSalus Life Sciences, Inc.
Other people whose current roles at this company are on record from its filings.
- Mary Szela CEO, Board Member
- Karim Karti Chairman
- Mats Wahlström Chairman, Board Member
- David B. Patience CFO
- David Patience CFO
- James Young CFO, Head of Investor Relations
- Anil Singhal Board Member
- Arjun Desai Board Member
- Gary Gordon Board Member
- George Kelly Martin Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.